Cargando…

Cryptotanshinone Is a Intervention for ER-Positive Breast Cancer: An Integrated Approach to the Study of Natural Product Intervention Mechanisms

Background: Resistance to endocrine therapy has hampered clinical treatment in patients with ER-positive breast cancer (BRCA). Studies have confirmed that cryptotanshinone (CPT) has cytotoxic effects on BRCA cells and can significantly inhibit the proliferation and metastasis of ER-positive cancer c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Huayao, Gao, Chundi, Liang, Qing, Liu, Cun, Liu, Lijuan, Zhuang, Jing, Yang, Jing, Zhou, Chao, Feng, Fubin, Sun, Changgang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832090/ https://www.ncbi.nlm.nih.gov/pubmed/33505309 http://dx.doi.org/10.3389/fphar.2020.592109

Ejemplares similares

The Modulatory Properties of Astragalus membranaceus Treatment on Triple-Negative Breast Cancer: An Integrated Pharmacological Method
por: Liu, Cun, et al.
Publicado: (2019)

Identifying the Effect of Ursolic Acid Against Triple-Negative Breast Cancer: Coupling Network Pharmacology With Experiments Verification
por: Zhang, Yubao, et al.
Publicado: (2021)

Development of a risk scoring system for evaluating the prognosis of patients with Her2-positive breast cancer
por: Gao, Chundi, et al.
Publicado: (2020)

Natural compounds: Wnt pathway inhibitors with therapeutic potential in lung cancer
por: Shen, Xuetong, et al.
Publicado: (2023)

Gene signatures of 6-methyladenine regulators in women with lung adenocarcinoma and development of a risk scoring system: a retrospective study using the cancer genome atlas database
por: Gao, Chundi, et al.
Publicado: (2021)

7-lncRNA Assessment Model for Monitoring and Prognosis of Breast Cancer Patients: Based on Cox Regression and Co-expression Analysis
por: Li, Huayao, et al.
Publicado: (2019)

Survival-Associated Metabolic Genes and Risk Scoring System in HER2-Positive Breast Cancer
por: Gao, Chundi, et al.
Publicado: (2022)

SNP mutation‐related genes in breast cancer for monitoring and prognosis of patients: A study based on the TCGA database
por: Gao, Chundi, et al.
Publicado: (2019)

Tumor Mutation Burden and Immune Invasion Characteristics in Triple Negative Breast Cancer: Genome High-Throughput Data Analysis
por: Gao, Chundi, et al.
Publicado: (2021)

Identification of key candidate genes and miRNA-mRNA target pairs in chronic lymphocytic leukemia by integrated bioinformatics analysis
por: Gao, Chundi, et al.
Publicado: (2019)

Integrated Proteomics and Metabolomics Link Acne to the Action Mechanisms of Cryptotanshinone Intervention
por: Zhu, Zhaoming, et al.
Publicado: (2021)

Exploration of methylation-driven genes for monitoring and prognosis of patients with lung adenocarcinoma
por: Gao, Chundi, et al.
Publicado: (2018)

Identifying the Antiproliferative Effect of Astragalus Polysaccharides on Breast Cancer: Coupling Network Pharmacology With Targetable Screening From the Cancer Genome Atlas
por: Liu, Cun, et al.
Publicado: (2019)

Determination of Genetic and Epigenetic Modifications-Related Prognostic Biomarkers of Breast Cancer: Genome High-Throughput Data Analysis
por: Gao, Chundi, et al.
Publicado: (2021)

Construction and Analysis of Competing Endogenous RNA Networks for Breast Cancer Based on TCGA Dataset
por: Wang, Xue, et al.
Publicado: (2020)

Deciphering the mechanism of Indirubin and its derivatives in the inhibition of Imatinib resistance using a “drug target prediction-gene microarray analysis-protein network construction” strategy
por: Li, Huayao, et al.
Publicado: (2019)

Identification of key candidate targets and pathways for the targeted treatment of leukemia stem cells of chronic myelogenous leukemia using bioinformatics analysis
por: Li, Huayao, et al.
Publicado: (2019)

From tumor mutational burden to characteristic targets analysis: Identifying the predictive biomarkers and natural product interventions in cancer management
por: Liu, Cun, et al.
Publicado: (2022)

Comprehensive Analysis of Gene Signatures of m6ARNA Methylation Regulators in Lung Adenocarcinoma and Development of a Risk Scoring System
por: Gao, Chundi, et al.
Publicado: (2022)

Combinatorial regimens of chemotherapeutic agents: A new perspective on raising the heat of the tumor immune microenvironment
por: Liu, Jingyang, et al.
Publicado: (2022)

Deciphering Key Pharmacological Pathways of Qingdai Acting on Chronic Myeloid Leukemia Using a Network Pharmacology-Based Strategy
por: Li, Huayao, et al.
Publicado: (2018)

Target Analysis and Mechanism of Podophyllotoxin in the Treatment of Triple-Negative Breast Cancer
por: Zhang, Wenfeng, et al.
Publicado: (2020)

The construction and analysis of ceRNA networks in invasive breast cancer: a study based on The Cancer Genome Atlas
por: Gao, Chundi, et al.
Publicado: (2018)

Exploring the Mechanism of Danshen against Myelofibrosis by Network Pharmacology and Molecular Docking
por: Li, Jie, et al.
Publicado: (2018)

Nanoformulations of Ursolic Acid: A Modern Natural Anticancer Molecule
por: Wang, Longyun, et al.
Publicado: (2021)

Efficacy and safety of de-escalation bone- modifying agents for cancer patients with bone metastases: a systematic review and meta-analysis
por: Liu, Cun, et al.
Publicado: (2018)

Immunogenomic landscape analyses of immune molecule signature-based risk panel for patients with triple-negative breast cancer
por: Liu, Cun, et al.
Publicado: (2022)

A Systems Biology-Based Approach to Uncovering Molecular Mechanisms Underlying Effects of Traditional Chinese Medicine Qingdai in Chronic Myelogenous Leukemia, Involving Integration of Network Pharmacology and Molecular Docking Technology
por: Zhou, Chao, et al.
Publicado: (2018)

A Novel Glycolysis-Related Four-mRNA Signature for Predicting the Survival of Patients With Breast Cancer
por: Zhang, Xiaolu, et al.
Publicado: (2021)

Commentary: The Modulation of Chaihu Shugan Formula on Microbiota Composition in the Simulator of the Human Intestinal Microbial Ecosystem Technology Platform and Its Influence on Gut Barrier and Intestinal Immunity in Caco-2/THP1-Blue™ Cell Co-Culture Model
por: Yu, Yang, et al.
Publicado: (2022)

Pharmacokinetics and tissue distribution of bleomycin-induced idiopathic pulmonary fibrosis rats treated with cryptotanshinone
por: He, Xiangjun, et al.
Publicado: (2023)

Natural Polysaccharides and Their Derivates: A Promising Natural Adjuvant for Tumor Immunotherapy
por: Li, Ye, et al.
Publicado: (2021)

Uncovering the Mechanisms of Cryptotanshinone as a Therapeutic Agent Against Hepatocellular Carcinoma
por: Luo, Yi, et al.
Publicado: (2020)

Preparation and optimization of surface stabilized cryptotanshinone nanocrystals with enhanced bioavailability
por: Zhao, Wenzheng, et al.
Publicado: (2023)

Anticancer potential of cryptotanshinone on breast cancer treatment; A narrative review
por: Dalil, Davood, et al.
Publicado: (2022)

Application Potential of Plant-Derived Medicines in Prevention and Treatment of Platinum-Induced Peripheral Neurotoxicity
por: Xu, Xiaowei, et al.
Publicado: (2022)

Deciphering of Key Pharmacological Pathways of Poria Cocos Intervention in Breast Cancer Based on Integrated Pharmacological Method
por: Ma, Xiaoran, et al.
Publicado: (2020)

Synergistic Effects of Cryptotanshinone and Senkyunolide I in Guanxinning Tablet Against Endogenous Thrombus Formation in Zebrafish
por: Li, Jun, et al.
Publicado: (2021)

Cryptotanshinone protects skin cells from ultraviolet radiation-induced photoaging via its antioxidant effect and by reducing mitochondrial dysfunction and inhibiting apoptosis
por: Guo, Keke, et al.
Publicado: (2022)

Comparative Proteomics Analysis Reveals the Reversal Effect of Cryptotanshinone on Gefitinib-Resistant Cells in Epidermal Growth Factor Receptor-Mutant Lung Cancer
por: Cai, Peiheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d1j9nfemcp0e8i8frjvs0fupli